AbbVie Inc news

   Watch this stock
Showing stories 1 - 10 of about 163   

Articles published

ABBV 100.34 0.00 (0.00%)
price chart
Better Stock: AbbVie Inc (ABBV) vs. Johnson & Johnson (JNJ)
But as much promise as AbbVie's drugs have, the moat they provide is forever tenuous. Had the Amgen situation gone the other way, AbbVie could have been looking at steep declines in Humira sales in 2018. There is little way to predict with any level of ...
AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 11, 2018  Nasdaq
Your Daily Pharma Scoop: AbbVie Highlights Pipeline, Novavax Surges ...  Seeking Alpha
Here's How AbbVie Inc. Crushed It in 2017
AbbVie may have added a few chapters to Humira's growth story, but its sales can't grow forever. This year, AbbVie hit another home run with an experimental psoriasis drug that could go a long way to offset the impending losses. Stelara is a popular ...
Revenue Approximations Analysis: AbbVie Inc. (ABBV), The Williams Companies ...
Investors who are keeping close eye on the stock of AbbVie Inc. (NYSE:ABBV) established that the company was able to keep return on investment at 11.73 in the trailing twelve month while Reuters data showed that industry's average stands at 15.00 and ...
With An ROE Of 101.06%, Has AbbVie Inc's (NYSE:ABBV) Management Done A ...  Simply Wall St
AbbVie Inc (NYSE:ABBV) Shares Sold by Supplemental Annuity Collective Trust ...  The Ledger Gazette
AbbVie Inc Dividend at Risk Amid Patent Protection Problems
AbbVie Inc (NYSE:ABBV) is firing on all cylinders right now. ABBV stock is one of the Dividend Aristocrats, a group of 51 companies in the S&P 500 Index, with 25+ consecutive years of dividend increases.
$1.43 EPS Expected for AbbVie Inc. (ABBV)  Frisco Fastball
Drilling Down Into AbbVie Inc. (ABBV)  StockNewsJournal
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Looking at the universe of stocks we cover at Dividend Channel , on 1/11/18, Patterson Companies Inc (Symbol: PDCO), AbbVie Inc (Symbol: ABBV), and Abbott Laboratories (Symbol: ABT) will all trade ex-dividend for their respective upcoming dividends ...
These two are the must watch stock's for the fearless investors: AbbVie Inc ...
AbbVie Inc. (NYSE:ABBV) market capitalization at present is $160.24B at the rate of $100.34 a share. The firm's price-to-sales ratio was noted 5.86 in contrast with an overall industry average of 4.05.
FinTrust Investment Advisory Services LLC Invests $582000 in AbbVie Inc ...  The Ledger Gazette
Abbvie INC (ABBV) Stock Price Rose While Advisors Asset Management INC ...  Frisco Fastball
What the Numbers Say About AbbVie Inc. (ABBV) and Eli Lilly and Company (LLY)
AbbVie Inc. (NYSE:ABBV) and Eli Lilly and Company (NYSE:LLY) are both Healthcare companies that recently hit new highs. Naturally, this has caught the attention of the investment community.
Effectively hedging the stocks in today's share market: AbbVie Inc. (ABBV)
The top gainer with a security that increased in price during today's trading was AbbVie Inc. (NYSE:ABBV). AbbVie Inc. had a higher price at the close than it did at the open. The company holds a market cap of 160.24B with a P/E of 24.37 indicating ...
Stock Investors Should Fear Valuation Of AbbVie Inc. (ABBV), Corbus ...
AbbVie Inc. (NYSE:ABBV) current P/S is an unimpressive 5.86. The overall Drug Manufacturers - Major group has an average P/S ratio of 4.13, which is significantly better than the sector's 6.56.
Can AbbVie (ABBV) Stock Keep the Momentum Alive in 2018?
Meanwhile, AbbVie gained regulatory approvals in the United States, Europe, and Japan for its competitive HCV medicine Mavyret and FDA approval for the sixth indication for cancer drug Imbruvica in 2018.
Can AbbVie Inc. (ABBV)'s Tomorrow be Different? The Stock Just Broke Its ...  Frisco Fastball
Exane Derivatives Has $2.74 Million Position in AbbVie Inc (ABBV)  The Ledger Gazette